2017 Session Laws

CHAPTER 155

(SB 95)

Cannabidiol added to the list of Schedule IV controlled substances.


        ENTITLED, An Act to add cannabidiol to the list of Schedule IV controlled substances and to exclude it from the definition of marijuana.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF SOUTH DAKOTA:

    Section 1. That subdivision (12) of § 34-20B-1 be amended to read:

            (12)    "Marijuana," all parts of any plant of the genus cannabis, whether growing or not; the seeds thereof; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant or its seeds; but. The term does not include fiber produced from the mature stalks of such the plant, or oil or cake made from the seeds of such the plant, or the resin when extracted from any part of such the plant or cannabidiol, a drug product approved by the United States Food and Drug Administration;

    Section 2. That § 34-20B-25 be amended to read:

    34-20B-25. The following are included in Schedule IV:

            (1)    Chlordiazepoxide, but not including librax (chlordiazepoxide hydrochloride and clindinium bromide) or menrium (chlordiazepoxide and water soluble esterified estrogens);

            (2)    Clonazepam;

            (3)    Clorazepate;

            (4)    Diazepam;

            (4A)    Flunitrazepam;

            (5)    Flurazepam;

            (6)    Mebutamate;

            (7)    Oxazepam;

            (8)    Prazepam;

            (9)    Lorazepam;

            (10)    Triazolam;

            (11)    Any substance which contains any quantity of a benzodiazepine, or salt of benzodiazepine, except substances which are specifically listed in other schedules;

            (11A)    Alprazolam;

            (11B)    Midazolam;

            (11C)    Temazepam;

            (12)    Repealed by SL 2003, ch 183, § 4;

            (13)    Cathine;

            (14)    Fencamfamine;

            (15)    Fenproporex;

            (16)    Mefenorex;

            (17)    Pyrovalerone;

            (18)    Propoxyphene;

            (19)    Pentazocine;

            (20)    Diethylpropion;

            (21)    Ethchlorvynol;

            (22)    Ethinamate;

            (23)    Fenfluramine;

            (24)    Mazindol;

            (25)    Mephobarbital;

            (26)    Methohexitol;

            (27)    Paraldehyde;

            (28)    Pemoline;

            (29)    Petrichloral;

            (30)    Phentermine;

            (31)    Barbital;

            (32)    Phenobarbital;

            (33)    Meprobamate;

            (34)    Zolpidem;

            (35)    Butorphanol;

            (36)    Modafinil, including its salts, isomers, and salts of isomers;

            (37)    Sibutramine;

            (38)    Zaleplon;

            (39)    Dichloralphenazone;

            (40)    Zopiclone (also known as eszopiclone), including its salts, isomers, and salts of isomers;

            (41)    Pregabalin;

            (42)    Lacosamide;

            (43)    Fospropofol, including its salts, isomers, and salts of isomers;

            (44)    Clobazam;

            (45)    Carisoprodol, including its salts, isomers, and salts of isomers;

            (46)    Ezogabine,[-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester], including its salts, isomers, and salts of isomers;

            (47)    Lorcaserin, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible;

            (48)    Alfaxalone, 5[alpha]-pregnan-3[alpha]-ol-11,20-dione, including its salts, isomers, and salts of isomers;

            (49)    Tramadol, 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers;

            (50)    Suvorexant, including its salts, isomers, and salts of isomers; and

            (51)    Eluxadoline,(5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxop ropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) including its optical isomers and its salts, isomers, and salts of isomers; and

            (52)    Cannabidiol.

     Signed March 17, 2017
_______________